|
Acurx Pharmaceuticals, Inc.
|
- USD
|
NaN%
|
|
Adaptive Biotechnologies Corporation
|
130.66 Million USD
|
100.0%
|
|
IO Biotech, Inc.
|
1.83 Million USD
|
100.0%
|
|
VYNE Therapeutics Inc.
|
99 Thousand USD
|
100.0%
|
|
Organovo Holdings, Inc.
|
888 Thousand USD
|
100.0%
|
|
TNF Pharmaceuticals, Inc.
|
- USD
|
NaN%
|
|
Lexaria Bioscience Corp.
|
136.17 Thousand USD
|
100.0%
|
|
Tonix Pharmaceuticals Holding Corp.
|
6.56 Million USD
|
100.0%
|
|
Aadi Bioscience, Inc.
|
833 Thousand USD
|
100.0%
|
|
Savara Inc.
|
26.34 Million USD
|
100.0%
|
|
Aerovate Therapeutics, Inc.
|
255 Thousand USD
|
100.0%
|
|
Rocket Pharmaceuticals, Inc.
|
22.32 Million USD
|
100.0%
|
|
Corbus Pharmaceuticals Holdings, Inc.
|
3.23 Million USD
|
100.0%
|
|
ZyVersa Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Soligenix, Inc.
|
1.01 Million USD
|
100.0%
|
|
Aptose Biosciences Inc.
|
621 Thousand USD
|
100.0%
|
|
NKGen Biotech, Inc. Common Stock
|
9.93 Million USD
|
100.0%
|
|
Century Therapeutics, Inc.
|
46.65 Million USD
|
100.0%
|
|
Eterna Therapeutics Inc.
|
6.77 Million USD
|
100.0%
|
|
Precision BioSciences, Inc.
|
7.72 Million USD
|
100.0%
|
|
Axsome Therapeutics, Inc.
|
178.07 Million USD
|
100.0%
|
|
Kura Oncology, Inc.
|
9.33 Million USD
|
100.0%
|
|
Xenetic Biosciences, Inc.
|
- USD
|
NaN%
|
|
Dyadic International, Inc.
|
88.87 Thousand USD
|
100.0%
|
|
TScan Therapeutics, Inc.
|
26.7 Million USD
|
100.0%
|
|
IDEAYA Biosciences, Inc.
|
1.12 Million USD
|
100.0%
|
|
CytomX Therapeutics, Inc.
|
9.38 Million USD
|
100.0%
|
|
Autolus Therapeutics plc
|
47.91 Million USD
|
100.0%
|
|
Eton Pharmaceuticals, Inc.
|
22 Thousand USD
|
100.0%
|
|
EyePoint Pharmaceuticals, Inc.
|
4.9 Million USD
|
100.0%
|
|
GRI Bio, Inc.
|
- USD
|
NaN%
|
|
Tenaya Therapeutics, Inc.
|
8.1 Million USD
|
100.0%
|
|
IGM Biosciences, Inc.
|
34.67 Million USD
|
100.0%
|
|
Heron Therapeutics, Inc.
|
173.75 Million USD
|
100.0%
|
|
SAB Biotherapeutics, Inc.
|
4.05 Million USD
|
100.0%
|
|
Entero Therapeutics, Inc.
|
146.94 Thousand USD
|
100.0%
|
|
Opthea Limited
|
200.53 Million USD
|
100.0%
|
|
X4 Pharmaceuticals, Inc.
|
54.57 Million USD
|
100.0%
|
|
Atara Biotherapeutics, Inc.
|
45.69 Million USD
|
100.0%
|
|
Pliant Therapeutics, Inc.
|
10.05 Million USD
|
100.0%
|
|
Ligand Pharmaceuticals Incorporated
|
5.75 Million USD
|
100.0%
|
|
Surrozen, Inc.
|
882 Thousand USD
|
100.0%
|
|
Lixte Biotechnology Holdings, Inc.
|
- USD
|
NaN%
|
|
Cingulate Inc.
|
135.09 Thousand USD
|
100.0%
|
|
Ovid Therapeutics Inc.
|
30 Million USD
|
100.0%
|
|
Sorrento Therapeutics, Inc.
|
104.33 Million USD
|
100.0%
|
|
Acelyrin, Inc.
|
1.19 Million USD
|
100.0%
|
|
Centessa Pharmaceuticals plc
|
75.7 Million USD
|
100.0%
|
|
Hepion Pharmaceuticals, Inc.
|
93.1 Thousand USD
|
100.0%
|
|
Arcturus Therapeutics Holdings Inc.
|
25.9 Million USD
|
100.0%
|
|
Syros Pharmaceuticals, Inc.
|
34.55 Million USD
|
100.0%
|
|
ADMA Biologics, Inc.
|
130.59 Million USD
|
100.0%
|
|
PureTech Health plc
|
18.25 Million USD
|
100.0%
|
|
Oncternal Therapeutics, Inc.
|
145 Thousand USD
|
100.0%
|
|
FibroBiologics, Inc. Common Stock
|
1.38 Million USD
|
100.0%
|
|
Barinthus Biotherapeutics plc
|
11.19 Million USD
|
100.0%
|
|
Kymera Therapeutics, Inc.
|
78.32 Million USD
|
100.0%
|
|
Synaptogenix, Inc.
|
- USD
|
NaN%
|
|
Tiziana Life Sciences Ltd
|
109 Thousand USD
|
100.0%
|
|
ChromaDex Corporation
|
2.57 Million USD
|
100.0%
|
|
Inhibikase Therapeutics, Inc.
|
90.12 Thousand USD
|
100.0%
|
|
Monopar Therapeutics Inc.
|
- USD
|
NaN%
|
|
Exelixis, Inc.
|
189.94 Million USD
|
100.0%
|
|
Akebia Therapeutics, Inc.
|
71.19 Million USD
|
100.0%
|
|
Better Therapeutics, Inc.
|
10.34 Million USD
|
100.0%
|
|
Nurix Therapeutics, Inc.
|
23.12 Million USD
|
100.0%
|
|
Apellis Pharmaceuticals, Inc.
|
93.03 Million USD
|
100.0%
|
|
Sangamo Therapeutics, Inc.
|
33.51 Million USD
|
100.0%
|
|
Seer, Inc.
|
25.96 Million USD
|
100.0%
|
|
Aridis Pharmaceuticals, Inc.
|
1.29 Million USD
|
100.0%
|
|
LAVA Therapeutics N.V.
|
591 Thousand USD
|
100.0%
|
|
Gritstone bio, Inc.
|
40.14 Million USD
|
100.0%
|
|
Jasper Therapeutics, Inc.
|
1.81 Million USD
|
100.0%
|
|
Avid Bioservices, Inc.
|
153.59 Million USD
|
100.0%
|
|
Insmed Incorporated
|
1.19 Billion USD
|
100.0%
|
|
Panbela Therapeutics, Inc.
|
4.19 Million USD
|
100.0%
|
|
Avalo Therapeutics, Inc.
|
2 Million USD
|
100.0%
|
|
Fate Therapeutics, Inc.
|
97.36 Million USD
|
100.0%
|
|
MediWound Ltd.
|
6.35 Million USD
|
100.0%
|
|
BioXcel Therapeutics, Inc.
|
100.59 Million USD
|
100.0%
|
|
Fortress Biotech, Inc.
|
60.85 Million USD
|
100.0%
|
|
OmniAb, Inc.
|
22.07 Million USD
|
100.0%
|
|
Seres Therapeutics, Inc.
|
101.54 Million USD
|
100.0%
|
|
Zai Lab Limited
|
8.04 Million USD
|
100.0%
|
|
Revance Therapeutics, Inc.
|
426.59 Million USD
|
100.0%
|
|
Tarsus Pharmaceuticals, Inc.
|
29.81 Million USD
|
100.0%
|
|
Veracyte, Inc.
|
7.52 Million USD
|
100.0%
|
|
Abeona Therapeutics Inc.
|
4.4 Million USD
|
100.0%
|
|
FibroGen, Inc.
|
89.69 Million USD
|
100.0%
|
|
Apogee Therapeutics, Inc.
|
933 Thousand USD
|
100.0%
|
|
ContextLogic Inc.
|
6 Million USD
|
100.0%
|
|
Intensity Therapeutics, Inc.
|
138 Thousand USD
|
100.0%
|
|
Adial Pharmaceuticals, Inc.
|
- USD
|
NaN%
|
|
HOOKIPA Pharma Inc.
|
3.8 Million USD
|
100.0%
|
|
Jazz Pharmaceuticals plc
|
5.1 Billion USD
|
100.0%
|
|
Entrada Therapeutics, Inc.
|
60.32 Million USD
|
100.0%
|
|
Cyclacel Pharmaceuticals, Inc.
|
37 Thousand USD
|
100.0%
|
|
ImmuCell Corporation
|
10.54 Million USD
|
100.0%
|
|
Fortrea Holdings Inc.
|
1.63 Billion USD
|
100.0%
|
|
KalVista Pharmaceuticals, Inc.
|
6.01 Million USD
|
100.0%
|
|
Jasper Therapeutics, Inc.
|
1.81 Million USD
|
100.0%
|
|
Foghorn Therapeutics Inc.
|
36.55 Million USD
|
100.0%
|
|
Ultragenyx Pharmaceutical Inc.
|
30.57 Million USD
|
100.0%
|
|
Theravance Biopharma, Inc.
|
45.23 Million USD
|
100.0%
|
|
Metagenomi, Inc. Common Stock
|
44.8 Million USD
|
100.0%
|
|
Vaxxinity, Inc.
|
13.26 Million USD
|
100.0%
|
|
BioCryst Pharmaceuticals, Inc.
|
811.26 Million USD
|
100.0%
|
|
Gain Therapeutics, Inc.
|
449.05 Thousand USD
|
100.0%
|
|
Creative Medical Technology Holdings, Inc.
|
- USD
|
NaN%
|
|
Marker Therapeutics, Inc.
|
- USD
|
NaN%
|
|
CASI Pharmaceuticals, Inc.
|
18.89 Million USD
|
100.0%
|
|
Senti Biosciences, Inc.
|
33.53 Million USD
|
100.0%
|
|
BioRestorative Therapies, Inc.
|
- USD
|
NaN%
|
|
Apollomics, Inc.
|
267 Thousand USD
|
100.0%
|
|
89bio, Inc.
|
24.79 Million USD
|
100.0%
|
|
Arrowhead Pharmaceuticals, Inc.
|
104.6 Million USD
|
100.0%
|
|
TransCode Therapeutics, Inc.
|
38.29 Thousand USD
|
100.0%
|
|
RAPT Therapeutics, Inc.
|
4.45 Million USD
|
100.0%
|
|
Ardelyx, Inc.
|
51.54 Million USD
|
100.0%
|
|
Pluri Inc.
|
29.05 Million USD
|
100.0%
|
|
Prothena Corporation plc
|
10.72 Million USD
|
100.0%
|
|
Pulmatrix, Inc.
|
8.32 Million USD
|
100.0%
|
|
Celularity Inc.
|
26.17 Million USD
|
100.0%
|
|
MeiraGTx Holdings plc
|
72.11 Million USD
|
100.0%
|
|
Omeros Corporation
|
329.7 Million USD
|
100.0%
|
|
Ainos, Inc.
|
5.92 Million USD
|
100.0%
|
|
Humacyte, Inc.
|
38.6 Million USD
|
100.0%
|
|
Mesoblast Limited
|
100.48 Million USD
|
100.0%
|
|
Cocrystal Pharma, Inc.
|
1.61 Million USD
|
100.0%
|
|
Cidara Therapeutics, Inc.
|
3.57 Million USD
|
100.0%
|
|
Blueprint Medicines Corporation
|
610.96 Million USD
|
100.0%
|
|
Cabaletta Bio, Inc.
|
1.45 Million USD
|
100.0%
|
|
Summit Therapeutics Inc.
|
103.29 Million USD
|
100.0%
|
|
Alaunos Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Scholar Rock Holding Corporation
|
48.68 Million USD
|
100.0%
|
|
Intellia Therapeutics, Inc.
|
96.74 Million USD
|
100.0%
|
|
Adlai Nortye Ltd. American Depositary Shares
|
469 Thousand USD
|
100.0%
|
|
Cytokinetics, Incorporated
|
607.37 Million USD
|
100.0%
|
|
Eloxx Pharmaceuticals, Inc.
|
8.69 Million USD
|
100.0%
|
|
Nutriband Inc.
|
79.82 Thousand USD
|
100.0%
|
|
Protara Therapeutics, Inc.
|
4.48 Million USD
|
100.0%
|
|
Roivant Sciences Ltd.
|
477.85 Million USD
|
100.0%
|
|
Evogene Ltd.
|
10.65 Million USD
|
100.0%
|
|
Applied Therapeutics, Inc.
|
759 Thousand USD
|
100.0%
|
|
Hoth Therapeutics, Inc.
|
26.32 Thousand USD
|
100.0%
|
|
BridgeBio Pharma, Inc.
|
1.73 Billion USD
|
100.0%
|
|
BioLineRx Ltd.
|
6.62 Million USD
|
100.0%
|
|
Atai Life Sciences N.V.
|
15.21 Million USD
|
100.0%
|
|
VistaGen Therapeutics, Inc.
|
1.57 Million USD
|
100.0%
|
|
Aurinia Pharmaceuticals Inc.
|
82 Million USD
|
100.0%
|
|
MediciNova, Inc.
|
410.66 Thousand USD
|
100.0%
|
|
Praxis Precision Medicines, Inc.
|
1.36 Million USD
|
100.0%
|
|
MiMedx Group, Inc.
|
48.09 Million USD
|
100.0%
|
|
PTC Therapeutics, Inc.
|
284.21 Million USD
|
100.0%
|
|
Cullinan Oncology, Inc.
|
2.15 Million USD
|
100.0%
|
|
Syndax Pharmaceuticals, Inc.
|
588 Thousand USD
|
100.0%
|
|
Pasithea Therapeutics Corp.
|
- USD
|
NaN%
|
|
NRx Pharmaceuticals, Inc.
|
- USD
|
NaN%
|
|
4D Molecular Therapeutics, Inc.
|
11.52 Million USD
|
100.0%
|
|
Dyne Therapeutics, Inc.
|
22.69 Million USD
|
100.0%
|
|
Kiniksa Pharmaceuticals, Ltd.
|
10 Million USD
|
100.0%
|
|
Ventyx Biosciences, Inc.
|
11.5 Million USD
|
100.0%
|
|
Allakos Inc.
|
38.21 Million USD
|
100.0%
|
|
Fulcrum Therapeutics, Inc.
|
8.62 Million USD
|
100.0%
|
|
Corcept Therapeutics Incorporated
|
- USD
|
NaN%
|
|
BioAtla, Inc.
|
836 Thousand USD
|
100.0%
|
|
Allogene Therapeutics, Inc.
|
88.34 Million USD
|
100.0%
|
|
Larimar Therapeutics, Inc.
|
4.7 Million USD
|
100.0%
|
|
Precigen, Inc.
|
5.89 Million USD
|
100.0%
|
|
BriaCell Therapeutics Corp.
|
- USD
|
NaN%
|
|
XOMA Corporation
|
118.51 Million USD
|
100.0%
|
|
Kezar Life Sciences, Inc.
|
10.06 Million USD
|
100.0%
|
|
Incyte Corporation
|
29.16 Million USD
|
100.0%
|
|
Cara Therapeutics, Inc.
|
37.07 Million USD
|
100.0%
|
|
Aligos Therapeutics, Inc.
|
7.89 Million USD
|
100.0%
|
|
Reviva Pharmaceuticals Holdings, Inc.
|
- USD
|
NaN%
|
|
CRISPR Therapeutics AG
|
223 Million USD
|
100.0%
|
|
Akero Therapeutics, Inc.
|
24.96 Million USD
|
100.0%
|
|
Eliem Therapeutics, Inc.
|
15 Thousand USD
|
100.0%
|
|
EyeGate Pharmaceuticals, Inc.
|
278.19 Thousand USD
|
100.0%
|
|
UroGen Pharma Ltd.
|
98.55 Million USD
|
100.0%
|
|
Sutro Biopharma, Inc.
|
149.11 Million USD
|
100.0%
|
|
ZIVO Bioscience, Inc.
|
- USD
|
NaN%
|
|
Lisata Therapeutics, Inc.
|
137.00 USD
|
100.0%
|
|
Stoke Therapeutics, Inc.
|
4.77 Million USD
|
100.0%
|
|
Chimerix, Inc.
|
125 Thousand USD
|
100.0%
|
|
Outlook Therapeutics, Inc.
|
- USD
|
NaN%
|
|
60 Degrees Pharmaceuticals, Inc.
|
150.25 Thousand USD
|
100.0%
|
|
Enanta Pharmaceuticals, Inc.
|
21.23 Million USD
|
100.0%
|
|
Aprea Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Portage Biotech Inc.
|
7000.00 USD
|
100.0%
|
|
OncoCyte Corporation
|
2.2 Million USD
|
100.0%
|
|
Qualigen Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Cadrenal Therapeutics, Inc. Common Stock
|
- USD
|
NaN%
|
|
Processa Pharmaceuticals, Inc.
|
66.9 Thousand USD
|
100.0%
|
|
Purple Biotech Ltd.
|
163 Thousand USD
|
100.0%
|
|
NextCure, Inc.
|
5.94 Million USD
|
100.0%
|
|
ProMIS Neurosciences, Inc.
|
- USD
|
NaN%
|
|
Dermata Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Generation Bio Co.
|
89.77 Million USD
|
100.0%
|
|
Neumora Therapeutics, Inc. Common Stock
|
1.85 Million USD
|
100.0%
|
|
Xeris Biopharma Holdings, Inc.
|
190.93 Million USD
|
100.0%
|
|
TRACON Pharmaceuticals, Inc.
|
732 Thousand USD
|
100.0%
|
|
NLS Pharmaceutics AG
|
- USD
|
NaN%
|
|
Mineralys Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Novavax, Inc.
|
168.01 Million USD
|
100.0%
|
|
Virios Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Curis, Inc.
|
1.48 Million USD
|
100.0%
|
|
Daré Bioscience, Inc.
|
3.91 Million USD
|
100.0%
|
|
Titan Pharmaceuticals, Inc.
|
- USD
|
NaN%
|
|
Virpax Pharmaceuticals, Inc.
|
- USD
|
NaN%
|
|
Bicycle Therapeutics plc
|
40.08 Million USD
|
100.0%
|
|
BeiGene, Ltd.
|
197.61 Million USD
|
100.0%
|
|
Kiromic BioPharma, Inc.
|
911.5 Thousand USD
|
100.0%
|
|
Alector, Inc.
|
30.45 Million USD
|
100.0%
|
|
Protagonist Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Erasca, Inc.
|
51.88 Million USD
|
100.0%
|
|
Checkpoint Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Aura Biosciences, Inc.
|
16.87 Million USD
|
100.0%
|
|
Viracta Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Chemomab Therapeutics Ltd.
|
316 Thousand USD
|
100.0%
|
|
Protagenic Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Pieris Pharmaceuticals, Inc.
|
- USD
|
NaN%
|
|
BioMarin Pharmaceutical Inc.
|
593.09 Million USD
|
100.0%
|
|
Histogen Inc.
|
4.38 Million USD
|
100.0%
|
|
Fortress Biotech, Inc.
|
60.85 Million USD
|
100.0%
|
|
Avidity Biosciences, Inc.
|
6.21 Million USD
|
100.0%
|
|
Lyell Immunopharma, Inc.
|
56.89 Million USD
|
100.0%
|
|
Galecto, Inc.
|
66 Thousand USD
|
100.0%
|
|
InMed Pharmaceuticals Inc.
|
644.86 Million USD
|
100.0%
|
|
Phathom Pharmaceuticals, Inc.
|
138.3 Million USD
|
100.0%
|
|
Molecular Templates, Inc.
|
9.74 Million USD
|
100.0%
|
|
PDS Biotechnology Corporation
|
19.5 Million USD
|
100.0%
|
|
Amylyx Pharmaceuticals, Inc.
|
1.98 Million USD
|
100.0%
|
|
Amarin Corporation plc
|
8.73 Million USD
|
100.0%
|
|
TG Therapeutics, Inc.
|
100.11 Million USD
|
100.0%
|
|
Aptevo Therapeutics Inc.
|
5.39 Million USD
|
100.0%
|
|
Celldex Therapeutics, Inc.
|
928 Thousand USD
|
100.0%
|
|
Cogent Biosciences, Inc.
|
17.46 Million USD
|
100.0%
|
|
Onconetix, Inc.
|
118.85 Thousand USD
|
100.0%
|
|
MacroGenics, Inc.
|
30.19 Million USD
|
100.0%
|
|
Y-mAbs Therapeutics, Inc.
|
517 Thousand USD
|
100.0%
|
|
Ocuphire Pharma, Inc.
|
- USD
|
NaN%
|
|
Adagene Inc.
|
13.54 Million USD
|
100.0%
|
|
Inhibrx Biosciences, Inc.
|
206.96 Million USD
|
100.0%
|
|
Cartesian Therapeutics, Inc.
|
8.78 Million USD
|
100.0%
|
|
Voyager Therapeutics, Inc.
|
17.09 Million USD
|
100.0%
|
|
SciSparc Ltd.
|
24 Thousand USD
|
100.0%
|
|
Revelation Biosciences, Inc.
|
- USD
|
NaN%
|
|
Minerva Neurosciences, Inc.
|
82.01 Million USD
|
100.0%
|
|
Astria Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Black Diamond Therapeutics, Inc.
|
22.18 Million USD
|
100.0%
|
|
Arcutis Biotherapeutics, Inc.
|
201.79 Million USD
|
100.0%
|
|
Relay Therapeutics, Inc.
|
48.5 Million USD
|
100.0%
|
|
Alnylam Pharmaceuticals, Inc.
|
2.34 Billion USD
|
100.0%
|
|
Artelo Biosciences, Inc.
|
23 Thousand USD
|
100.0%
|
|
2seventy bio, Inc.
|
244.01 Million USD
|
100.0%
|
|
Clene Inc.
|
7.15 Million USD
|
100.0%
|
|
Boundless Bio, Inc. Common Stock
|
247.61 Million USD
|
100.0%
|
|
GeoVax Labs, Inc.
|
- USD
|
NaN%
|
|
Sonnet BioTherapeutics Holdings, Inc.
|
130.86 Thousand USD
|
100.0%
|
|
Arbutus Biopharma Corporation
|
6.95 Million USD
|
100.0%
|
|
Scopus BioPharma Inc.
|
- USD
|
NaN%
|
|
Absci Corporation
|
4.66 Million USD
|
100.0%
|
|
XBiotech Inc.
|
- USD
|
NaN%
|
|
ALX Oncology Holdings Inc.
|
9.63 Million USD
|
100.0%
|
|
Lyra Therapeutics, Inc.
|
21.44 Million USD
|
100.0%
|
|
Entera Bio Ltd.
|
256 Thousand USD
|
100.0%
|
|
Trevena, Inc.
|
35.23 Million USD
|
100.0%
|
|
Adaptimmune Therapeutics plc
|
19.85 Million USD
|
100.0%
|
|
Caribou Biosciences, Inc.
|
25.9 Million USD
|
100.0%
|
|
INmune Bio, Inc.
|
397 Thousand USD
|
100.0%
|
|
Citius Pharmaceuticals, Inc.
|
262.86 Thousand USD
|
100.0%
|
|
Tyra Biosciences, Inc.
|
6.21 Million USD
|
100.0%
|
|
Galmed Pharmaceuticals Ltd.
|
- USD
|
NaN%
|
|
Unity Biotechnology, Inc.
|
23.53 Million USD
|
100.0%
|
|
Tenax Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Jaguar Health, Inc.
|
30.99 Million USD
|
100.0%
|
|
Clearside Biomedical, Inc.
|
41.98 Million USD
|
100.0%
|
|
NexImmune, Inc.
|
- USD
|
NaN%
|
|
Connect Biopharma Holdings Limited
|
180 Thousand USD
|
100.0%
|
|
Clearmind Medicine Inc.
|
- USD
|
NaN%
|
|
Coeptis Therapeutics Holdings, Inc.
|
150 Thousand USD
|
100.0%
|
|
Kronos Bio, Inc.
|
25.37 Million USD
|
100.0%
|
|
Innoviva, Inc.
|
446.23 Million USD
|
100.0%
|
|
Coherus BioSciences, Inc.
|
473.36 Million USD
|
100.0%
|
|
Regeneron Pharmaceuticals, Inc.
|
2.7 Billion USD
|
100.0%
|
|
Bolt Biotherapeutics, Inc.
|
17.43 Million USD
|
100.0%
|
|
Verastem, Inc.
|
40.08 Million USD
|
100.0%
|
|
ProKidney Corp.
|
3.61 Million USD
|
100.0%
|
|
CERo Therapeutics Holdings, Inc.
|
- USD
|
NaN%
|
|
Imunon, Inc.
|
1.13 Million USD
|
100.0%
|
|
Viking Therapeutics, Inc.
|
936 Thousand USD
|
100.0%
|
|
Statera Biopharma, Inc.
|
11.43 Million USD
|
100.0%
|
|
ImmunityBio, Inc.
|
836.95 Million USD
|
100.0%
|
|
Korro Bio, Inc.
|
31.21 Million USD
|
100.0%
|
|
Travere Therapeutics, Inc.
|
377.26 Million USD
|
100.0%
|
|
Kineta, Inc.
|
150 Thousand USD
|
100.0%
|
|
Catalyst Pharmaceuticals, Inc.
|
3.18 Million USD
|
100.0%
|
|
Capricor Therapeutics, Inc.
|
3.37 Million USD
|
100.0%
|
|
GT Biopharma, Inc.
|
- USD
|
NaN%
|
|
Keros Therapeutics, Inc.
|
13.43 Million USD
|
100.0%
|
|
Celularity Inc.
|
26.17 Million USD
|
100.0%
|
|
Crinetics Pharmaceuticals, Inc.
|
47.55 Million USD
|
100.0%
|
|
CalciMedica, Inc.
|
- USD
|
NaN%
|
|
Cibus, Inc.
|
17.67 Million USD
|
100.0%
|
|
C4 Therapeutics, Inc.
|
65.75 Million USD
|
100.0%
|
|
Marinus Pharmaceuticals, Inc.
|
95.18 Million USD
|
100.0%
|
|
Eledon Pharmaceuticals, Inc.
|
- USD
|
NaN%
|
|
Kodiak Sciences Inc.
|
100 Million USD
|
100.0%
|
|
Sana Biotechnology, Inc.
|
90.9 Million USD
|
100.0%
|
|
Annexon, Inc.
|
29.19 Million USD
|
100.0%
|
|
Adverum Biotechnologies, Inc.
|
64.62 Million USD
|
100.0%
|
|
Assembly Biosciences, Inc.
|
1.12 Million USD
|
100.0%
|
|
Elicio Therapeutics, Inc.
|
6 Million USD
|
100.0%
|
|
Moderna, Inc.
|
- USD
|
NaN%
|
|
Vigil Neuroscience, Inc.
|
12.94 Million USD
|
100.0%
|
|
Ionis Pharmaceuticals, Inc.
|
1.4 Billion USD
|
100.0%
|
|
Vor Biopharma Inc.
|
31.83 Million USD
|
100.0%
|
|
Eyenovia, Inc.
|
8.95 Million USD
|
100.0%
|
|
DiaMedica Therapeutics Inc.
|
317 Thousand USD
|
100.0%
|
|
Puma Biotechnology, Inc.
|
65.65 Million USD
|
100.0%
|
|
Monte Rosa Therapeutics, Inc.
|
42.87 Million USD
|
100.0%
|
|
Wave Life Sciences Ltd.
|
25.4 Million USD
|
100.0%
|
|
Conduit Pharmaceuticals Inc.
|
- USD
|
NaN%
|
|
ACADIA Pharmaceuticals Inc.
|
47.8 Million USD
|
100.0%
|
|
Immunocore Holdings plc
|
82.64 Million USD
|
100.0%
|
|
Tango Therapeutics, Inc.
|
36.83 Million USD
|
100.0%
|
|
Galectin Therapeutics Inc.
|
71.74 Million USD
|
100.0%
|
|
Alkermes plc
|
287.73 Million USD
|
100.0%
|
|
Arcellx, Inc.
|
50.84 Million USD
|
100.0%
|
|
Renovaro Biosciences Inc.
|
842.38 Thousand USD
|
100.0%
|
|
Zentalis Pharmaceuticals, Inc.
|
43.15 Million USD
|
100.0%
|
|
Sagimet Biosciences Inc.
|
- USD
|
NaN%
|
|
Regulus Therapeutics Inc.
|
1.05 Million USD
|
100.0%
|
|
Cardio Diagnostics Holdings, Inc.
|
663.09 Thousand USD
|
100.0%
|
|
Moolec Science SA
|
99.04 Thousand USD
|
100.0%
|
|
Biomea Fusion, Inc.
|
7.83 Million USD
|
100.0%
|
|
RenovoRx, Inc.
|
- USD
|
NaN%
|
|
Geron Corporation
|
35.05 Million USD
|
100.0%
|
|
Mereo BioPharma Group plc
|
5.3 Million USD
|
100.0%
|
|
Verrica Pharmaceuticals Inc.
|
42.87 Million USD
|
100.0%
|
|
Royalty Pharma plc
|
6.13 Billion USD
|
100.0%
|
|
Atea Pharmaceuticals, Inc.
|
1.64 Million USD
|
100.0%
|
|
Greenwich LifeSciences, Inc.
|
- USD
|
NaN%
|
|
Calithera Biosciences, Inc.
|
136 Thousand USD
|
100.0%
|
|
TFF Pharmaceuticals, Inc.
|
31.74 Thousand USD
|
100.0%
|
|
Mersana Therapeutics, Inc.
|
23.14 Million USD
|
100.0%
|
|
Humacyte, Inc.
|
38.6 Million USD
|
100.0%
|
|
Structure Therapeutics Inc.
|
4.01 Million USD
|
100.0%
|
|
NLS Pharmaceutics AG
|
- USD
|
NaN%
|
|
Genelux Corporation
|
1.86 Million USD
|
100.0%
|
|
ESSA Pharma Inc.
|
- USD
|
NaN%
|
|
aTyr Pharma, Inc.
|
13.76 Million USD
|
100.0%
|
|
Notable Labs, Ltd.
|
1.52 Million USD
|
100.0%
|
|
Alzamend Neuro, Inc.
|
- USD
|
NaN%
|
|
Mustang Bio, Inc.
|
1.97 Million USD
|
100.0%
|
|
Immunovant, Inc.
|
- USD
|
NaN%
|
|
Tevogen Bio Holdings Inc.
|
14.45 Million USD
|
100.0%
|
|
Vericel Corporation
|
81.85 Million USD
|
100.0%
|
|
Halozyme Therapeutics, Inc.
|
1.49 Billion USD
|
100.0%
|
|
Akari Therapeutics, Plc
|
- USD
|
NaN%
|
|
Acasti Pharma Inc.
|
- USD
|
NaN%
|
|
MiNK Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Vaxcyte, Inc.
|
22.11 Million USD
|
100.0%
|
|
Orgenesis Inc.
|
19.06 Million USD
|
100.0%
|
|
Spruce Biosciences, Inc.
|
1.71 Million USD
|
100.0%
|
|
NeuroBo Pharmaceuticals, Inc.
|
136 Thousand USD
|
100.0%
|
|
GH Research PLC
|
631 Thousand USD
|
100.0%
|
|
Tempest Therapeutics, Inc.
|
6.26 Million USD
|
100.0%
|
|
PepGen Inc.
|
17.1 Million USD
|
100.0%
|
|
Moleculin Biotech, Inc.
|
474 Thousand USD
|
100.0%
|
|
Relmada Therapeutics, Inc.
|
- USD
|
NaN%
|
|
BriaCell Therapeutics Corp.
|
- USD
|
NaN%
|
|
Lixte Biotechnology Holdings, Inc.
|
- USD
|
NaN%
|
|
Silo Pharma, Inc.
|
- USD
|
NaN%
|
|
Telomir Pharmaceuticals, Inc. Common Stock
|
- USD
|
NaN%
|
|
Belite Bio, Inc
|
578 Thousand USD
|
100.0%
|
|
Pharming Group N.V.
|
166.1 Million USD
|
100.0%
|
|
XOMA Corporation
|
118.51 Million USD
|
100.0%
|
|
Reneo Pharmaceuticals, Inc.
|
642 Thousand USD
|
100.0%
|
|
Reviva Pharmaceuticals Holdings, Inc.
|
- USD
|
NaN%
|
|
Bionomics Limited
|
117.62 Million USD
|
100.0%
|
|
Xencor, Inc.
|
14.64 Million USD
|
100.0%
|
|
Replimune Group, Inc.
|
71.99 Million USD
|
100.0%
|
|
Pyxis Oncology, Inc.
|
20.09 Million USD
|
100.0%
|
|
Cassava Sciences, Inc.
|
- USD
|
NaN%
|
|
Vanda Pharmaceuticals Inc.
|
7 Million USD
|
100.0%
|
|
Estrella Immunopharma, Inc.
|
- USD
|
NaN%
|
|
Turnstone Biologics Corp.
|
1.18 Million USD
|
100.0%
|
|
Windtree Therapeutics, Inc.
|
15 Million USD
|
100.0%
|
|
GeoVax Labs, Inc.
|
- USD
|
NaN%
|
|
MEI Pharma, Inc.
|
- USD
|
NaN%
|
|
Olema Pharmaceuticals, Inc.
|
1.42 Million USD
|
100.0%
|
|
Cardio Diagnostics Holdings, Inc.
|
663.09 Thousand USD
|
100.0%
|
|
Bio-Path Holdings, Inc.
|
10 Thousand USD
|
100.0%
|
|
Enlivex Therapeutics Ltd.
|
686 Thousand USD
|
100.0%
|
|
CollPlant Biotechnologies Ltd.
|
2.53 Million USD
|
100.0%
|
|
scPharmaceuticals Inc.
|
38.81 Million USD
|
100.0%
|
|
HilleVax, Inc.
|
25.24 Million USD
|
100.0%
|
|
Vera Therapeutics, Inc.
|
49.87 Million USD
|
100.0%
|
|
Tharimmune, Inc.
|
- USD
|
NaN%
|
|
Genprex, Inc.
|
- USD
|
NaN%
|
|
SeaStar Medical Holding Corporation
|
4.33 Million USD
|
100.0%
|
|
Immunic, Inc.
|
639 Thousand USD
|
100.0%
|
|
Atossa Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Aptorum Group Limited
|
3.05 Million USD
|
100.0%
|
|
Soleno Therapeutics, Inc.
|
130 Thousand USD
|
100.0%
|
|
SeaStar Medical Holding Corporation
|
4.33 Million USD
|
100.0%
|
|
OKYO Pharma Limited
|
- USD
|
NaN%
|
|
Carmell Therapeutics Corporation
|
697.71 Thousand USD
|
100.0%
|
|
Achieve Life Sciences, Inc.
|
6000.00 USD
|
100.0%
|
|
Ocean Biomedical, Inc.
|
- USD
|
NaN%
|
|
Amicus Therapeutics, Inc.
|
387.85 Million USD
|
100.0%
|
|
Salarius Pharmaceuticals, Inc.
|
- USD
|
NaN%
|
|
bluebird bio, Inc.
|
224.41 Million USD
|
100.0%
|
|
DBV Technologies S.A.
|
4.52 Million USD
|
100.0%
|
|
Compugen Ltd.
|
719 Thousand USD
|
100.0%
|
|
Protagenic Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Peak Bio, Inc.
|
- USD
|
NaN%
|
|
Vincerx Pharma, Inc.
|
1.34 Million USD
|
100.0%
|
|
Fresh Tracks Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Sensei Biotherapeutics, Inc.
|
3.76 Million USD
|
100.0%
|
|
Orchestra BioMed Holdings, Inc.
|
1.03 Million USD
|
100.0%
|
|
Zevra Therapeutics, Inc.
|
5.06 Million USD
|
100.0%
|
|
Acrivon Therapeutics, Inc. Common Stock
|
3.76 Million USD
|
100.0%
|
|
Benitec Biopharma Inc.
|
- USD
|
NaN%
|
|
Spyre Therapeutics, Inc.
|
84.55 Million USD
|
100.0%
|
|
Adicet Bio, Inc.
|
17.7 Million USD
|
100.0%
|
|
Prime Medicine, Inc.
|
4.35 Million USD
|
100.0%
|
|
Aditxt, Inc.
|
1.04 Million USD
|
100.0%
|
|
Madrigal Pharmaceuticals, Inc.
|
115.48 Million USD
|
100.0%
|
|
Estrella Immunopharma, Inc.
|
- USD
|
NaN%
|
|
Quantum-Si incorporated
|
13.73 Million USD
|
100.0%
|
|
GlycoMimetics, Inc.
|
66.84 Thousand USD
|
100.0%
|
|
PolyPid Ltd.
|
6.37 Million USD
|
100.0%
|
|
Aileron Therapeutics, Inc.
|
91.41 Million USD
|
100.0%
|
|
Invivyd, Inc.
|
722 Thousand USD
|
100.0%
|
|
Quoin Pharmaceuticals, Ltd.
|
2923.73 USD
|
100.0%
|
|
Rigel Pharmaceuticals, Inc.
|
52.65 Million USD
|
100.0%
|
|
CorMedix Inc.
|
517.01 Thousand USD
|
100.0%
|
|
Instil Bio, Inc.
|
81.42 Million USD
|
100.0%
|
|
Recursion Pharmaceuticals, Inc.
|
1.1 Million USD
|
100.0%
|
|
Contineum Therapeutics, Inc. Class A Common Stock
|
192.62 Million USD
|
100.0%
|
|
Finch Therapeutics Group, Inc.
|
28.4 Million USD
|
100.0%
|
|
Spero Therapeutics, Inc.
|
3.82 Million USD
|
100.0%
|
|
Alpha Tau Medical Ltd.
|
5.61 Million USD
|
100.0%
|
|
AbCellera Biologics Inc.
|
71.22 Million USD
|
100.0%
|
|
Ocular Therapeutix, Inc.
|
74.92 Million USD
|
100.0%
|
|
Surrozen, Inc.
|
882 Thousand USD
|
100.0%
|
|
Janux Therapeutics, Inc.
|
23.02 Million USD
|
100.0%
|
|
Verona Pharma plc
|
48.37 Million USD
|
100.0%
|
|
Terns Pharmaceuticals, Inc.
|
- USD
|
NaN%
|
|
Vir Biotechnology, Inc.
|
111.67 Million USD
|
100.0%
|
|
Evaxion Biotech A/S
|
8.48 Million USD
|
100.0%
|
|
Verve Therapeutics, Inc.
|
64.71 Million USD
|
100.0%
|
|
Shattuck Labs, Inc.
|
3.4 Million USD
|
100.0%
|
|
AlloVir, Inc.
|
16.64 Million USD
|
100.0%
|
|
BioVie Inc.
|
349.89 Thousand USD
|
100.0%
|
|
Codexis, Inc.
|
12.24 Million USD
|
100.0%
|
|
SELLAS Life Sciences Group, Inc.
|
460 Thousand USD
|
100.0%
|
|
Lexaria Bioscience Corp.
|
136.17 Thousand USD
|
100.0%
|
|
Agenus Inc.
|
137.32 Million USD
|
100.0%
|
|
Virax Biolabs Group Limited
|
176.34 Thousand USD
|
100.0%
|
|
Lantern Pharma Inc.
|
61.49 Thousand USD
|
100.0%
|
|
Viridian Therapeutics, Inc.
|
20.2 Million USD
|
100.0%
|
|
eFFECTOR Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Immix Biopharma, Inc.
|
- USD
|
NaN%
|
|
Celcuity Inc.
|
37.03 Million USD
|
100.0%
|
|
Cardiff Oncology, Inc.
|
1.45 Million USD
|
100.0%
|
|
Acumen Pharmaceuticals, Inc.
|
27.62 Million USD
|
100.0%
|
|
IN8bio, Inc.
|
3.37 Million USD
|
100.0%
|
|
Avenue Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Trevi Therapeutics, Inc.
|
1.03 Million USD
|
100.0%
|
|
Lexicon Pharmaceuticals, Inc.
|
99.5 Million USD
|
100.0%
|
|
Liquidia Corporation
|
2.36 Million USD
|
100.0%
|
|
Quantum-Si incorporated
|
13.73 Million USD
|
100.0%
|
|
Pasithea Therapeutics Corp.
|
- USD
|
NaN%
|
|
Xenon Pharmaceuticals Inc.
|
9.6 Million USD
|
100.0%
|
|
Sol-Gel Technologies Ltd.
|
1.2 Million USD
|
100.0%
|
|
United Therapeutics Corporation
|
300 Million USD
|
100.0%
|
|
Solid Biosciences Inc.
|
23.94 Million USD
|
100.0%
|
|
Immuneering Corporation
|
4.16 Million USD
|
100.0%
|
|
Alpha Tau Medical Ltd.
|
5.61 Million USD
|
100.0%
|
|
uniQure N.V.
|
130.06 Million USD
|
100.0%
|
|
Xilio Therapeutics, Inc.
|
8.14 Million USD
|
100.0%
|
|
Enveric Biosciences, Inc.
|
- USD
|
NaN%
|
|
Poseida Therapeutics, Inc.
|
58.59 Million USD
|
100.0%
|
|
Longboard Pharmaceuticals, Inc.
|
- USD
|
NaN%
|
|
PMV Pharmaceuticals, Inc.
|
12.43 Million USD
|
100.0%
|
|
Elevai Labs, Inc. Common Stock
|
65.48 Thousand USD
|
100.0%
|
|
Cue Biopharma, Inc.
|
4.2 Million USD
|
100.0%
|
|
Nuvectis Pharma, Inc.
|
- USD
|
NaN%
|
|
ARS Pharmaceuticals, Inc.
|
37 Thousand USD
|
100.0%
|
|
Zura Bio Limited
|
- USD
|
NaN%
|
|
Forte Biosciences, Inc.
|
- USD
|
NaN%
|
|
Elevation Oncology, Inc.
|
30.13 Million USD
|
100.0%
|
|
Conduit Pharmaceuticals Inc.
|
- USD
|
NaN%
|
|
Immunome, Inc.
|
1.34 Million USD
|
100.0%
|
|
Compass Therapeutics, Inc.
|
536 Thousand USD
|
100.0%
|
|
enGene Holdings Inc. Warrants
|
9.21 Million USD
|
100.0%
|
|
Inovio Pharmaceuticals, Inc.
|
11.03 Million USD
|
100.0%
|
|
LENZ Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Altimmune, Inc.
|
175 Thousand USD
|
100.0%
|
|
Milestone Pharmaceuticals Inc.
|
49.77 Million USD
|
100.0%
|
|
Rallybio Corporation
|
173 Thousand USD
|
100.0%
|
|
Plus Therapeutics, Inc.
|
85 Thousand USD
|
100.0%
|
|
Dianthus Therapeutics, Inc.
|
168 Thousand USD
|
100.0%
|
|
Moolec Science SA
|
99.04 Thousand USD
|
100.0%
|
|
Anebulo Pharmaceuticals, Inc.
|
- USD
|
NaN%
|
|
XTL Biopharmaceuticals Ltd.
|
- USD
|
NaN%
|
|
Tourmaline Bio, Inc.
|
194 Thousand USD
|
100.0%
|
|
NeurAxis, Inc.
|
27.07 Thousand USD
|
100.0%
|
|
Maravai LifeSciences Holdings, Inc.
|
518.7 Million USD
|
100.0%
|
|
Lumos Pharma, Inc.
|
6 Million USD
|
100.0%
|
|
enGene Holdings Inc. Common Stock
|
9.21 Million USD
|
100.0%
|
|
180 Life Sciences Corp.
|
19.93 Thousand USD
|
100.0%
|
|
NKGen Biotech, Inc. Warrants
|
9.93 Million USD
|
100.0%
|
|
Opiant Pharmaceuticals, Inc.
|
16.74 Million USD
|
100.0%
|
|
CERo Therapeutics Holdings, Inc.
|
- USD
|
NaN%
|
|
Nutriband Inc.
|
79.82 Thousand USD
|
100.0%
|
|
CG Oncology, Inc. Common stock
|
13 Thousand USD
|
100.0%
|
|
argenx SE
|
15.35 Million USD
|
100.0%
|
|
Neurogene Inc.
|
13.37 Million USD
|
100.0%
|
|
Mirum Pharmaceuticals, Inc.
|
306.42 Million USD
|
100.0%
|
|
Kintara Therapeutics, Inc.
|
- USD
|
NaN%
|
|
CervoMed Inc.
|
- USD
|
NaN%
|
|
CARGO Therapeutics, Inc. Common Stock
|
26.26 Million USD
|
100.0%
|
|
Sesen Bio, Inc.
|
- USD
|
NaN%
|
|
AnaptysBio, Inc.
|
16.03 Million USD
|
100.0%
|
|
Design Therapeutics, Inc.
|
2.33 Million USD
|
100.0%
|
|
Leap Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Seelos Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Achilles Therapeutics plc
|
1.07 Million USD
|
100.0%
|
|
NeuroSense Therapeutics Ltd.
|
73 Thousand USD
|
100.0%
|
|
ORIC Pharmaceuticals, Inc.
|
7461.00 USD
|
100.0%
|
|
Fractyl Health, Inc. Common Stock
|
342.48 Million USD
|
100.0%
|
|
Rani Therapeutics Holdings, Inc.
|
24.48 Million USD
|
100.0%
|
|
MoonLake Immunotherapeutics
|
2.49 Million USD
|
100.0%
|
|
Palisade Bio, Inc.
|
90 Thousand USD
|
100.0%
|
|
Beam Therapeutics Inc.
|
159.91 Million USD
|
100.0%
|
|
AEON Biopharma, Inc.
|
- USD
|
NaN%
|
|
Enliven Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Kiora Pharmaceuticals, Inc.
|
59.82 Thousand USD
|
100.0%
|
|
Iovance Biotherapeutics, Inc.
|
1 Million USD
|
100.0%
|
|
Taysha Gene Therapies, Inc.
|
40.5 Million USD
|
100.0%
|
|
Athira Pharma, Inc.
|
1.21 Million USD
|
100.0%
|
|
Vaccinex, Inc.
|
26 Thousand USD
|
100.0%
|
|
HCW Biologics Inc.
|
6.3 Million USD
|
100.0%
|
|
XOMA Corporation
|
118.51 Million USD
|
100.0%
|
|
Nektar Therapeutics
|
112.62 Million USD
|
100.0%
|
|
Arvinas, Inc.
|
800 Thousand USD
|
100.0%
|
|
Tevogen Bio Holdings Inc.
|
14.45 Million USD
|
100.0%
|
|
Merus N.V.
|
10.48 Million USD
|
100.0%
|
|
Omega Therapeutics, Inc.
|
14.88 Million USD
|
100.0%
|
|
Quince Therapeutics, Inc.
|
13.42 Million USD
|
100.0%
|
|
Rezolute, Inc.
|
1.66 Million USD
|
100.0%
|
|
Clene Inc.
|
7.15 Million USD
|
100.0%
|
|
Indaptus Therapeutics, Inc.
|
73.34 Thousand USD
|
100.0%
|
|
BeyondSpring Inc.
|
3.36 Million USD
|
100.0%
|
|
Synlogic, Inc.
|
12.49 Million USD
|
100.0%
|
|
Allarity Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Phio Pharmaceuticals Corp.
|
- USD
|
NaN%
|
|
Peak Bio, Inc.
|
- USD
|
NaN%
|
|
Werewolf Therapeutics, Inc.
|
32.65 Million USD
|
100.0%
|
|
Krystal Biotech, Inc.
|
6.62 Million USD
|
100.0%
|
|
Karyopharm Therapeutics Inc.
|
170.91 Million USD
|
100.0%
|
|
SpringWorks Therapeutics, Inc.
|
5.99 Million USD
|
100.0%
|
|
Lipella Pharmaceuticals Inc.
|
47.37 Thousand USD
|
100.0%
|
|
MannKind Corporation
|
252.15 Million USD
|
100.0%
|
|
Ikena Oncology, Inc.
|
7.18 Million USD
|
100.0%
|
|
Cyclerion Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Gyre Therapeutics, Inc.
|
199 Thousand USD
|
100.0%
|
|
Gossamer Bio, Inc.
|
197.4 Million USD
|
100.0%
|
|
CohBar, Inc.
|
- USD
|
NaN%
|
|
Cognition Therapeutics, Inc.
|
520 Thousand USD
|
100.0%
|
|
NRx Pharmaceuticals, Inc.
|
- USD
|
NaN%
|
|
Legend Biotech Corporation
|
281.32 Million USD
|
100.0%
|
|
Mural Oncology plc
|
8.91 Million USD
|
100.0%
|
|
Biora Therapeutics, Inc.
|
43.73 Million USD
|
100.0%
|
|
PaxMedica, Inc. Common Stock
|
- USD
|
NaN%
|
|
Disc Medicine, Inc.
|
1.43 Million USD
|
100.0%
|
|
Champions Oncology, Inc.
|
6.09 Million USD
|
100.0%
|
|
REGENXBIO Inc.
|
82.22 Million USD
|
100.0%
|
|
Ensysce Biosciences, Inc.
|
- USD
|
NaN%
|
|
Anavex Life Sciences Corp.
|
- USD
|
NaN%
|
|
Cellectar Biosciences, Inc.
|
494 Thousand USD
|
100.0%
|
|
Edgewise Therapeutics, Inc.
|
4.43 Million USD
|
100.0%
|
|
Vaxart, Inc.
|
2.62 Million USD
|
100.0%
|
|
PharmaCyte Biotech, Inc.
|
- USD
|
NaN%
|
|
Aldeyra Therapeutics, Inc.
|
271.63 Thousand USD
|
100.0%
|
|
Cellectis S.A.
|
36.24 Million USD
|
100.0%
|
|
Longeveron Inc.
|
1.44 Million USD
|
100.0%
|
|
Repare Therapeutics Inc.
|
1.01 Million USD
|
100.0%
|
|
Sarepta Therapeutics, Inc.
|
1.13 Billion USD
|
100.0%
|
|
Inozyme Pharma, Inc.
|
44.76 Million USD
|
100.0%
|
|
Revolution Medicines, Inc.
|
80.57 Million USD
|
100.0%
|
|
Nymox Pharmaceutical Corporation
|
- USD
|
NaN%
|
|
Third Harmonic Bio, Inc.
|
3.2 Million USD
|
100.0%
|
|
ArriVent BioPharma, Inc. Common Stock
|
177 Thousand USD
|
100.0%
|
|
AN2 Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Anixa Biosciences, Inc.
|
123 Thousand USD
|
100.0%
|
|
Vertex Pharmaceuticals Incorporated
|
724.7 Million USD
|
100.0%
|
|
Denali Therapeutics Inc.
|
44.98 Million USD
|
100.0%
|
|
Revelation Biosciences, Inc.
|
- USD
|
NaN%
|
|
Veru Inc.
|
12.5 Million USD
|
100.0%
|
|
Corvus Pharmaceuticals, Inc.
|
- USD
|
NaN%
|
|
Cingulate Inc.
|
135.09 Thousand USD
|
100.0%
|
|
Passage Bio, Inc.
|
22.92 Million USD
|
100.0%
|
|
Context Therapeutics Inc.
|
- USD
|
NaN%
|
|
Exicure, Inc.
|
6.03 Million USD
|
100.0%
|
|
Day One Biopharmaceuticals, Inc.
|
- USD
|
NaN%
|
|
Oramed Pharmaceuticals Inc.
|
647 Thousand USD
|
100.0%
|
|
Revolution Medicines, Inc. Warrant
|
80.57 Million USD
|
100.0%
|
|
Scinai Immunotherapeutics Ltd.
|
20.16 Million USD
|
100.0%
|
|
Rhythm Pharmaceuticals, Inc.
|
490 Thousand USD
|
100.0%
|
|
Nuvalent, Inc.
|
- USD
|
NaN%
|
|
ABVC BioPharma, Inc.
|
407.45 Thousand USD
|
100.0%
|
|
Carisma Therapeutics, Inc.
|
1.18 Million USD
|
100.0%
|
|
Unicycive Therapeutics, Inc.
|
466 Thousand USD
|
100.0%
|
|
OmniAb, Inc.
|
22.07 Million USD
|
100.0%
|
|
Anew Medical, Inc.
|
1.54 Million USD
|
100.0%
|
|
Fennec Pharmaceuticals Inc.
|
29.55 Million USD
|
100.0%
|
|
Lipocine Inc.
|
- USD
|
NaN%
|
|
Lexeo Therapeutics, Inc. Common Stock
|
9.03 Million USD
|
100.0%
|
|
Nautilus Biotechnology, Inc.
|
31.09 Million USD
|
100.0%
|
|
SAB Biotherapeutics, Inc.
|
4.05 Million USD
|
100.0%
|
|
G1 Therapeutics, Inc.
|
51.55 Million USD
|
100.0%
|
|
Bellerophon Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Sage Therapeutics, Inc.
|
- USD
|
NaN%
|
|
Ocugen, Inc.
|
6.36 Million USD
|
100.0%
|
|
Mind Medicine (MindMed) Inc.
|
14.12 Million USD
|
100.0%
|
|
Q32 Bio Inc.
|
- USD
|
NaN%
|
|
Brainstorm Cell Therapeutics Inc.
|
672 Thousand USD
|
100.0%
|
|
Alumis Inc. Common Stock
|
30.86 Million USD
|
100.0%
|
|
Equillium, Inc.
|
384 Thousand USD
|
100.0%
|
|
Kyverna Therapeutics, Inc.
|
6.15 Million USD
|
100.0%
|
|
Coya Therapeutics, Inc.
|
- USD
|
NaN%
|
|
CNS Pharmaceuticals, Inc.
|
- USD
|
NaN%
|
|
Galera Therapeutics, Inc.
|
151.04 Million USD
|
100.0%
|
|
Evelo Biosciences, Inc.
|
48.87 Million USD
|
100.0%
|
|
Comera Life Sciences Holdings, Inc.
|
120.3 Thousand USD
|
100.0%
|
|
Dominari Holdings Inc.
|
3.02 Million USD
|
100.0%
|
|
Edesa Biotech, Inc.
|
19.77 Thousand USD
|
100.0%
|
|
vTv Therapeutics Inc.
|
169 Thousand USD
|
100.0%
|
|
Bio-Techne Corporation
|
319 Million USD
|
100.0%
|
|
Agios Pharmaceuticals, Inc.
|
56.98 Million USD
|
100.0%
|
|
Harmony Biosciences Holdings, Inc.
|
178.56 Million USD
|
100.0%
|
|
Prelude Therapeutics Incorporated
|
15.4 Million USD
|
100.0%
|
|
Candel Therapeutics, Inc.
|
12.38 Million USD
|
100.0%
|
|
iTeos Therapeutics, Inc.
|
4.8 Million USD
|
100.0%
|
|
Nkarta, Inc.
|
82.27 Million USD
|
100.0%
|
|
BioCardia, Inc.
|
982 Thousand USD
|
100.0%
|
|
Iterum Therapeutics plc
|
18.95 Million USD
|
100.0%
|
